# FMC Corp: Form 10-Q for the period ended Mar 31, 2019

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2019-05-08
- Accepted by EDGAR: May 8, 2019, 09:10 ET
- Period: 2019-03-31
- Accession: 0000037785-19-000071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778519000071/fmc03311910q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778519000071/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-01-01 to 2019-03-31 | $1.19bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-01-01 to 2019-03-31 | $647.4m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-01-01 to 2019-03-31 | $544.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2019-01-01 to 2019-03-31 | $183.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-01-01 to 2019-03-31 | $281.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-01-01 to 2019-03-31 | $36.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-01-01 to 2019-03-31 | $215.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-01-01 to 2019-03-31 | $1.62 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-01-01 to 2019-03-31 | $1.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-01-01 to 2019-03-31 | 133,214,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2019-01-01 to 2019-03-31 | −$282.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2019-01-01 to 2019-03-31 | $19.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2019-01-01 to 2019-03-31 | $53.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2019-01-01 to 2019-03-31 | $100.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-03-31 | $109.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-03-31 | $4.20bn | us-gaap:AssetsCurrent |
| Total assets | at 2019-03-31 | $9.95bn | us-gaap:Assets |
| Current liabilities | at 2019-03-31 | $3.34bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2019-03-31 | $2.15bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-03-31 | $385.6m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2019-03-31 | $608.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2019-03-31 | $2.76bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2019-03-31 | 131,657,750 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 51,211 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Information” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2018 Form 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2018 Form 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Revenue recognition and trade receivables
- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets and indefinite-lived assets
- Pensions and other postretirement benefits
- Income taxes

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are an agricultural sciences company providing innovative solutions to growers around the world with a robust product portfolio fueled by a market-driven discovery and development pipeline in crop protection, plant health, and professional pest and turf management. We operate in a single distinct business segment and develop, market and sell all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control.

### First Quarter 2019 Highlights

The following items are the more significant developments or financial highlights in our business during the three months ended March 31, 2019:

- On March 1, 2019, we successfully completed the separation of our FMC Lithium segment through a pro rata dividend on shares of FMC common stock which was a significant milestone and transformed FMC into a pure-play agricultural sciences company. The results of our FMC Lithium segment for periods up to separation are included within discontinued operations.
- Revenue of $1,192.1 million for the three months ended March 31, 2019 increased $84.2 million or approximately 8 percent versus the same period last year. A more detailed review of revenue is discussed under the section titled "Results of Operations". On a regional basis, sales in North America increased by approximately 7 percent, sales in Asia increased approximately 1 percent, sales in Latin America increased approximately 30 percent, and sales in Europe, Middle East and Africa increased by approximately 3 percent.
- Our gross margin, excluding transaction-related charges, of $544.7 million increased versus the prior year's first quarter by $12.3 million. Gross margin percent, excluding transaction-related charges, of approximately 46 percent decreased compared to approximately 48 percent in the prior year period.
- Selling, general and administrative expenses, excluding transaction-related charges, of $167.4 million slightly decreased compared to the prior year period.
- Research and development expenses of $71.2 million increased $6.3 million or approximately 10 percent. The increase was primarily due to continued investments in our global discovery and product development.
- Net income (loss) attributable to FMC stockholders decreased from $267.2 million to $215.7 million which represents a decrease of $51.5 million, or approximately 19 percent. The decrease was primarily due to a gain of $85.0 million from the sale of product portfolio in the prior year period that did not recur, partially offset by higher business results in the current period.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $229.3 million increased compared to the prior year amount of $214.9 million primarily due to higher gross margins driven by increased volumes and pricing in the current period. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### RESULTS OF OPERATIONS

### Overview

The following charts provide a reconciliation of Total Company Adjusted EBITDA ("Adjusted EBITDA") and Adjusted Earnings, both of which are Non-GAAP financial measures, from the most directly comparable GAAP measure. Total Company Adjusted EBITDA is provided to assist the readers of our financial statements with useful information regarding our operating results. Our operating results are presented based on how we assess operating performance and internally report financial information. For management purposes, we report operating performance based on earnings before interest, income taxes, and depreciation and amortization, and corporate special charges. Our Adjusted Earnings measure excludes corporate special charges, net of income taxes and discontinued operations attributable to FMC stockholders, net of income taxes. These are excluded by us in the measure we use to evaluate business performance and determine certain performance-based compensation. These items are discussed in detail within the “Other Results of Operations” section that follows. In addition to providing useful information about our operating results to investors, we also believe that excluding the effect of corporate special charges, net of income taxes, and certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying business from period to period. These measures should not be considered as substitutes for net income (loss) or other measures of performance or liquidity reported in accordance with U.S. GAAP.

*(in Millions)*

*(unaudited)*

| 2019 | Three Months Ended March 31, | 2018 |
| --- | ---: | ---: |
| **Revenue** | $1,192.1 | $1,107.9 |
| **Costs and Expenses** |  |  |
| Costs of sales and services | 647.4 | 605.4 |
| **Gross margin** | $544.7 | $502.5 |
| Selling, general and administrative expenses | 183.9 | 192.5 |
| Research and development expenses | 71.2 | 64.9 |
| Restructuring and other charges (income) | 7.8 | (79.9) |
| Total costs and expenses | $910.3 | $782.9 |
| Income from continuing operations before equity in (earnings) loss of affiliates, non-operating pension and postretirement charges (income), interest expense, net and income taxes | $281.8 | $325.0 |
| Equity in (earnings) loss of affiliates | — | (0.1) |
| Non-operating pension and postretirement charges (income) | 3.4 | 0.5 |
| Interest expense, net | 34.5 | 33.9 |
| Income (loss) from continuing operations before income taxes | $243.9 | $290.7 |
| Provision (benefit) for income taxes | 36.3 | 60.5 |
| Income (loss) from continuing operations | $207.6 | $230.2 |
| Discontinued operations, net of income taxes | 9.6 | 39.4 |
| **Net income (loss) (GAAP)** | **$217.2** | **$269.6** |
| Adjustments to arrive at Adjusted EBITDA: |  |  |
| Corporate special charges (income): |  |  |
| Restructuring and other (charges) income (2) | $7.8 | $(79.9) |
| Non-operating pension and postretirement (charges) income (3) | 3.4 | 0.5 |
| Transaction-related charges (4) | 16.5 | 49.5 |
| Discontinued operations, net of income taxes | (9.6) | (39.4) |
| Interest expense, net | 34.5 | 33.9 |
| Depreciation and amortization | 37.3 | 34.8 |
| Provision (benefit) for income taxes | 36.3 | 60.5 |
| **Adjusted EBITDA (Non-GAAP) (1)** | **$343.4** | **$329.5** |

(1) Referred to as Total Company Adjusted EBITDA. Defined as operating profit excluding corporate special charges (income) and depreciation and amortization expense.

(2) See Note 10 for details of restructuring and other charges (income).

(3) Our non-operating pension and postretirement charges (income) are defined as those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our operating results and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our operating results noted above. These elements reflect the current year operating costs to our business for the employment benefits provided to active employees.

(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, transaction costs, costs for transitional employees, other acquired employee related costs, and integration related legal and professional third-party fees. Amounts represent the following:

*(in Millions)*

| DuPont Crop Protection Business Acquisition | Three Months Ended March 31, 2019 | 2018 |
| --- | ---: | ---: |
| Legal and professional fees (1) | $16.5 | $19.6 |
| Inventory fair value amortization (2) | — | 29.9 |
| **Total Transaction-related charges** | **$16.5** | **$49.5** |

(1) Represents transaction costs, costs for transitional employees, other acquired employees related costs, and transactional-related costs such as legal and professional third-party fees. These charges are recorded as a component of “Selling, general and administrative expense" on the condensed consolidated statements of income (loss).

(2) These charges are recorded as a component of "Costs of sales and services" on the condensed consolidated statements of income (loss).

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2019 | Three Months Ended March 31, | 2018 |
| --- | ---: | ---: |
| **Net income (loss) attributable to FMC stockholders (GAAP)** | $215.7 | $267.2 |
| Corporate special charges (income), pre-tax (1) | 27.7 | (29.9) |
| Income tax expense (benefit) on Corporate special charges (income) (2) | (5.7) | 8.4 |
| Corporate special charges (income), net of income taxes | $22.0 | $(21.5) |
| Discontinued operations attributable to FMC Stockholders, net of income taxes | (9.6) | (39.4) |
| Non-GAAP tax adjustments (3) | 1.2 | 8.6 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | **$229.3** | **$214.9** |

(1) Represents restructuring and other charges (income), non-operating pension and postretirement charges (income) and transaction-related charges.

(2) The income tax expense (benefit) on corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the corporate special charge (income) occurred and includes both current and deferred income tax expense (benefit) based on the nature of the Non-GAAP performance measure.

(3) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but not limited to: income tax expenses or benefits that are not related to current year ongoing business operations; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law which includes the impact of the Act enacted on December 22, 2017. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

### Results of Operations

For management purposes, Adjusted EBITDA is defined as total revenue less operating expenses (operating expenses consist of costs of sales and services, selling, general and administrative expenses including corporate staff expense, and research and development expenses), excluding depreciation and amortization. We have excluded the following items from Adjusted EBITDA: interest income and expense associated with corporate debt facilities and investments, income taxes, gains (losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges (income), investment gains and losses, loss on extinguishment of debt, asset impairments, transaction-related charges, and other income and expense items.

In the discussion below, all comparisons are between the periods unless otherwise noted.

### Revenue

#### Three Months Ended March 31, 2019 vs. 2018

Revenue of $1,192.1 million increased $84.2 million, or approximately 8 percent, versus the prior year period. The increase was driven by higher volumes, which contributed approximately 9 percent to the increase, primarily in Latin America, as well as favorable pricing across all regions which impacted revenue by approximately 5 percent. Foreign currency had an unfavorable impact on the change in revenue of approximately 6 percent. The increase in revenue was driven by strong commercial execution and demand for our products. See below for a discussion of revenue by region.

*Total Revenue by Region*

*(in Millions)*

|  | Three Months Ended March 31, 2019 | 2018 |
| --- | ---: | ---: |
| North America | $318.3 | $298.2 |
| Latin America | 206.5 | 158.9 |
| Europe, Middle East & Africa (EMEA) | 412.0 | 398.8 |
| Asia Pacific | 255.3 | 252.0 |
| **Total Revenue** | **$1,192.1** | **$1,107.9** |

North America: Revenue increased approximately 7 percent versus the prior year period due to the launch of a new fungicide in addition to demand in pre-emergent herbicides for soybeans and insecticides for tree fruits and vegetables. These were partially offset by adverse weather conditions in the United States.

Latin America: Revenue increased approximately 30 percent versus the prior year period, or approximately 40 percent excluding foreign currency headwinds, primarily due to Brazil. Increased cotton acreage as well as a boll weevil infestation drove strong demand in Brazil for cotton insecticides. Additionally, demand for herbicides in sugarcane, as well as robust demand for our insecticides in soybean applications contributed to the increase in revenue. Price increases in the region offset nearly all the effects of negative foreign currency.

Europe, Middle East & Africa ("EMEA"): Revenue increased approximately 3 percent versus the prior year period, or approximately 11 percent excluding foreign currency headwinds, primarily due to favorable weather, demand for our diamide products, and higher pricing throughout the region. There were higher sales in Turkey and southwestern Europe, as well as new direct market access in Belgium and the Netherlands. These increases were partially offset by unfavorable foreign currency impacts.

Asia Pacific: Revenue increased approximately 1 percent versus the prior year period, or approximately 8 percent excluding foreign currency headwinds, due to the high growth in China driven by the diamide products. Additionally, the continued sales synergy in India and strong growth in Pakistan and Japan contributed to the increase in revenue. These factors were nearly offset by unfavorable foreign currency impacts, as well as unfavorable weather conditions in Australia.

In late March, there was an explosion within an industrial park in China which impacted one plant operated by one of our contract manufacturing tollers. The local government has temporarily shut down the entire park to investigate the cause of the explosion. The target date to reopen the industrial park is unknown at this time. However, FMC’s global manufacturing network provides significant supply chain flexibility. Due to the strength of our partnerships and our alternate sourcing options, we believe we can continue to secure supply of the active ingredients normally manufactured at this location as needed.

For 2019, full-year revenue is expected to be in the range of approximately $4.5 billion to $4.6 billion.

### Gross margin

#### Three Months Ended March 31, 2019 vs. 2018

Gross margin of $544.7 million increased $42.2 million, or approximately 8 percent versus the prior year period. Gross margin, excluding transaction-related charges, also increased versus the prior year period by $12.3 million. The increase was primarily due to the higher revenues which were driven by increased volumes and pricing, partially offset by higher raw material costs.

Gross margin percent of approximately 46 percent slightly increased from approximately 45 percent in the prior year period. The increase from higher pricing was nearly offset by higher raw material costs. Gross margin percent, excluding transaction-related charges, of approximately 46 percent decreased compared to approximately 48 percent in the prior year period primarily due to the higher costs and partially offset by increased pricing as discussed above.

### Selling, general and administrative expenses

#### Three Months Ended March 31, 2019 vs. 2018

Selling, general and administrative expenses of $183.9 million decreased $8.6 million, or approximately 4 percent versus the prior year period. Selling, general and administrative expenses, excluding transaction-related charges, also slightly decreased to $167.4 million, a $5.5 million, or approximately 3 percent, decrease. Favorable foreign currency impacts, primarily in Latin America, more than offset the incremental administrative expenses in Asia Pacific and EMEA.

### Research and development expenses

#### Three Months Ended March 31, 2019 vs. 2018

Research and development expenses of $71.2 million increased $6.3 million, or approximately 10 percent versus the prior year period. The increase was primarily due to continued investments in our global discovery and product development.

### Adjusted EBITDA

#### Three Months Ended March 31, 2019 vs. 2018

Adjusted EBITDA of $343.4 million increased $13.9 million, or approximately 4 percent versus the prior year period. The increase was due to the strong demand which led to higher volumes and higher pricing as discussed above which contributed 17 percent and 16 percent to the increase, respectively. The price increases were primarily seen in EMEA and Latin America. These factors more than offset the higher raw material costs and unfavorable foreign currency which impacted the change in Adjusted EBITDA by 17 percent and 12 percent, respectively.

For 2019, full-year Adjusted EBITDA is expected to be in the range of $1.18 billion to $1.22 billion. Although we provide a forecast for Adjusted EBITDA, a Non-GAAP financial measure, we are not able to forecast the most directly comparable measure calculated and presented in accordance with U.S. GAAP. Certain elements of the composition of the U.S. GAAP amount are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no U.S. GAAP outlook is provided.

### Other Results of Operations

### Depreciation and amortization

#### Three Months Ended March 31, 2019 vs. 2018

Depreciation and amortization of $37.3 million increased approximately 7 percent as compared to the prior year period of $34.8 million.

### Interest expense, net

#### Three Months Ended March 31, 2019 vs. 2018

Interest expense, net of $34.5 million slightly increased compared to the prior year period of $33.9 million. The increase was driven primarily by higher interest rates, partially offset by paydowns of both the 2014 and 2017 Term Loan Facilities.

### Corporate special charges (income)

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended March 31, 2019 | 2018 |
| --- | ---: | ---: |
| Restructuring charges | $5.2 | $2.6 |
| Other charges (income), net | 2.6 | (82.5) |
| **Total restructuring and other charges (income)** | **$7.8** | **$(79.9)** |

#### Three Months Ended March 31, 2019 vs. 2018

Restructuring and asset disposal charges in 2019 of $5.2 million primarily comprised of charges associated with the integration of the DuPont Crop Protection Business. These charges include severance, accelerated depreciation on certain fixed assets, and other costs (benefits) of $3.9 million. Additionally, charges include Corporate charges of $1.3 million.

Restructuring and asset disposal charges in 2018 of $2.6 million were primarily associated with charges of approximately $1 million of accelerated depreciation charges related to certain fixed assets that will no longer be used when we exit our Ewing R&D facility as well as miscellaneous restructuring efforts.

Other charges, net in 2019 of $2.6 million consists of charges of continuing environmental sites treated as a Corporate charge.

Other charges (income), net in 2018 of $(82.5) million primarily consists of a gain on sale of $85.0 million from the divestment of a portion of FMC's European herbicide portfolio to Nufarm Limited. This divestiture satisfied FMC's commitment to the European Commission for regulatory requirements in order to complete the DuPont Crop Protection Acquisition. The remaining other charges (income) represents $2.5 million of environmental related charges for remediation activities.

#### Non-operating pension and postretirement charges (income)

Charges for the three months ended March 31, 2019 was $3.4 million compared to $0.5 million for the three months ended March 31, 2018. The increase in expense was primarily due to a lower expected return on plan assets of $2.4 million. See Note 16 to the condensed consolidated financial statements included in this Form 10-Q for more information. Our U.S. qualified pensions plan reached fully funded status during 2018. The primary investment strategy is a liability hedging approach with an objective of maintain the funded status of the plan such that the funded status volatility is minimized.

#### Transaction-related charges

A detailed description of the transaction-related charges is included in Note 5 to the condensed consolidated financial statements included within this Form 10-Q.

### Provision for income taxes

A significant amount of our earnings are generated by foreign subsidiaries and taxed at lower statutory rates than the United States federal statutory rate (e.g., Singapore, Hong Kong, and Switzerland). Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance; changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States or foreign withholding taxes have not been previously accrued.

#### Three Months Ended March 31, 2019 vs. 2018

Provision for income taxes for the three months ended March 31, 2019 was $36.3 million resulting in an effective tax rate of 14.9 percent. Provision for income taxes for the three months ended March 31, 2018 was $60.5 million resulting in an effective tax rate of 20.8 percent. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 17 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.

*(in Millions)*

|  | Three Months Ended March 31, 2019 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2018 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP - Continuing operations** | $243.9 | $36.3 | 14.9% | $290.7 | $60.5 | 20.8% |
| Corporate special charges (income) | 27.7 | 5.7 |  | (29.9) | (8.4) |  |
| Tax adjustments (1) |  | (1.2) |  |  | (8.6) |  |
| **Non-GAAP - Continuing operations** | **$271.6** | **$40.8** | **15.0%** | **$260.8** | **$43.5** | **16.7%** |

(1) Refer to Note 3 of the *Adjusted Earnings Reconciliation* table within this section of this Form 10-Q for an explanation of tax adjustments.

The primary drivers for the decrease in the year-to-date effective tax rate for 2019 compared to 2018 are shown in the table above. The remaining change was due to the integration of the DuPont Crop Protection Business into our global supply chain.

### Discontinued operations, net of income taxes

Our discontinued operations include results of our discontinued FMC Lithium segment, in periods up to its separation on March 1, 2019, as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, stock compensation, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

#### Three Months Ended March 31, 2019 vs. 2018

Discontinued operations, net of income taxes representing income of $9.6 million for the three months ended March 31, 2019 decreased compared to income of $39.4 million for the three months ended March 31, 2018. During the three months ended March 31, 2019, we finalized the sale of the first of two parcels of land of our discontinued site in Newark, California and recorded a gain of approximately $21 million, net of tax. The gain on sale was partially offset by results of our discontinued FMC Lithium segment, including separation-related costs, as well as from other previously discontinued operations. Discontinued operations, net of income taxes for the three months ended March 31, 2018 includes an additional gain on sale of the FMC Health and Nutrition business to DuPont of approximately $16 million as a result of the adjustment to the final working capital. The prior year period also includes a full quarter of higher results from our discontinued FMC Lithium segment as compared two months during 2019. Refer to Note 12 to the condensed consolidated financial statements included within this Form 10-Q for further information.

### Net income (loss)

#### Three Months Ended March 31, 2019 vs. 2018

Net income (loss) decreased to $217.2 million from income of $269.6 million in the prior-year period. The decrease was primarily due to the gain on sale of $85.0 million from the divestment of a portion of FMC's European herbicide portfolio in the prior year period. This was partially offset by higher gross margins in the current period as discussed above.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at March 31, 2019 and December 31, 2018, were $109.5 million and $134.4 million, respectively. Of the cash and cash equivalents balance at March 31, 2019, $105.9 million were held by our foreign subsidiaries. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries’ operating activities and future foreign investments. We have not provided income taxes for other additional outside basis differences inherent in our investments in subsidiaries because the investments are essentially permanent in duration or we have concluded that no additional tax liability will arise upon disposal or remittance. Determining the amount of unrecognized deferred tax liability related to permanent undistributed foreign earnings is not practicable due to the complexity of the hypothetical calculation.

At March 31, 2019, we had total debt of $3,138.8 million as compared to $2,692.7 million at December 31, 2018. Total debt included $2,145.0 million and $2,145.0 million of long-term debt (excluding current portions of $385.6 million and $386.0 million) at March 31, 2019 and December 31, 2018, respectively. As of March 31, 2019, we were in compliance with all of our debt covenants. See Note 11 in the condensed consolidated financial statements included in this Form 10-Q for further details.

Short-term debt, which consists of borrowings under our commercial paper program as well as short-term foreign borrowings, increased from $547.7 million at December 31, 2018 to $993.8 million at March 31, 2019. The increase was primarily due to the increase in borrowings under our commercial paper program. Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. Proceeds from the commercial paper program were primarily used for the seasonal build in working capital and our continued purchases of FMC stock. At March 31, 2019, we had $493.5 million of borrowings under the commercial paper program and the average effective interest rate on the borrowings was 3.1 percent.

### Statement of Cash Flows

*Cash provided (required) by operating activities of continuing operations was $(282.9) million and $(67.4) million for the three months ended March 31, 2019 and 2018, respectively.*

The cash required for the three months ended March 31, 2019 was due to a more normal seasonal build of working capital. Additionally, the cash required was substantially more than the prior year period due to several non-recurring impacts that benefitted working capital in the prior year period including a step-down in past due balances in Brazil which reduced cash used for receivables, lower cash use for inventory, given inventory levels in the acquired DuPont Crop Protection Business at acquisition, and a significant increase in account payables associated with the ramp-up of the acquired DuPont Crop Protection Business post acquisition. The table below presents the components of cash provided (required) by operating activities of continuing operations.

*(in Millions)*

| 2019 | Three Months Ended March 31, | 2018 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, non-operating pension and postretirement charges (income), interest expense, net and income taxes | $281.8 | $325.0 |
| Restructuring and other charges (income), transaction-related charges and depreciation and amortization | 61.6 | 4.4 |
| **Operating income before depreciation and amortization (Non-GAAP)** | **$343.4** | **$329.4** |
| Change in trade receivables, net (1) | (389.4) | (331.4) |
| Change in inventories (2) | (109.7) | (59.8) |
| Change in accounts payable (3) | 91.0 | 207.3 |
| Change in accrued customer rebates (4) | 95.0 | 142.0 |
| Change in advance payments from customers (5) | (175.3) | (189.7) |
| Change in all other operating assets and liabilities (6) | (37.2) | (78.7) |
| **Operating cash flows (Non-GAAP)** | **$(182.2)** | **$19.1** |
| Restructuring and other spending (7) | $(5.8) | $(4.4) |
| Environmental spending, continuing, net of recoveries (8) | (3.5) | (2.0) |
| Pension and other postretirement benefit contributions (9) | (1.6) | (2.4) |
| Net interest payments (10) | (35.8) | (35.0) |
| Tax payments, net of refunds (10) | (34.1) | (8.7) |
| Transactional-related legal and professional fees (11) | (19.9) | (34.0) |
| **Cash provided (required) by operating activities of continuing operations** | **$(282.9)** | **$(67.4)** |

41

(1) Both periods include the impacts of seasonality and the receivable build intrinsic in our business. The change in cash flows related to trade receivables in 2019 was driven by timing of collections. Collection timing is more pronounced in certain countries such as Brazil where there may be terms significantly longer than the rest of our business. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks. During the three months ended March 31, 2019, we collected approximately $165 million of receivables in Brazil. Additionally, the prior year period included a step-down in past due balances in Brazil which reduced cash used for receivables.

(2) Changes in inventory are a result of inventory levels being adjusted to take into consideration the change in market conditions. Additionally, there was lower cash use for inventory in the prior year period, given inventory levels in the acquired DuPont Crop Protection Business at acquisition.

(3) The change in cash flows related to accounts payable is primarily due to timing of payments made to suppliers and vendors. Additionally, in the prior year period there was a significant increase in account payables associated with the ramp-up of the acquired DuPont Crop Protection Business post acquisition.

(4) These rebates are primarily associated within North America and Brazil and generally settle in the fourth quarter of each year. The changes year over year are associated with the mix in sales eligible for rebates and incentives in 2019 compared to 2018 and timing of rebate payments.

(5) Advance payments are primarily associated within North America and these payments are received in the fourth quarter of each year and recorded as deferred revenue on the balance sheet at December 31. Revenue associated with advance payments is recognized, generally in the first half of each year, as shipments are made and control to the customer takes place.

(6) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to vendors under our vendor finance program. Additionally, both periods include the effects of the unfavorable contracts amortization of approximately $27 million and $18 million, respectively.

(7) See Note 10 in our condensed consolidated financial statements included in this Form 10-Q for further details.

(8) The amounts represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(9) There were no voluntary contributions to our U.S. qualified defined benefit plan for the three months ended March 31, 2019 and 2018.

(10) Amounts shown in the chart represent net payments of our continuing operations.

(11) Represents payments for legal and professional fees associated with the DuPont's Crop Protection Business Acquisition. See Note 5 to the condensed consolidated financial statements included in this Form 10-Q for more information.

*Cash provided (required) by operating activities of discontinued operations was $5.7 million and $(11.0) million for the three months ended March 31, 2019 and 2018, respectively.*

Cash provided (required) by operating activities of discontinued operations is directly related to environmental, other postretirement benefit liabilities, stock compensation, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. Both periods include the operating activities related to our discontinued FMC Lithium segment while 2018 includes activity related to the divestiture of the FMC Health and Nutrition segment.

*Cash provided (required) by investing activities of continuing operations was $(33.4) million and $71.6 million for the three months ended March 31, 2019 and 2018, respectively.*

The decrease in cash provided during the three months ended March 31, 2019, as compared to the same period in 2018 was primarily due to proceeds from the sales of our product portfolio of approximately $85 million in the prior period that were required to complete the DuPont Crop Protection Business Acquisition. Additionally, there was higher capital expenditure spending and capitalizable corporate level spending associated with the implementation of a new SAP system in the current period.

*Cash provided (required) by investing activities of discontinued operations was $9.2 million and $(26.5) million for the three months ended March 31, 2019 and 2018, respectively.*

Cash provided by investing activities of discontinued operations for the three months ended March 31, 2019 represents the proceeds from the sale of the first of two parcels of land of our discontinued site in Newark, California partially offset by capital expenditures of our discontinued FMC Lithium segment. Cash required by investing activities of discontinued operations for the three months ended March 31, 2018 includes the final working capital payment associated with the divestiture of FMC Health and Nutrition as well as capital expenditures of our discontinued FMC Lithium segment.

*Cash provided (required) by financing activities of continuing operations was $287.6 million and $113.9 million for the three months ended March 31, 2019 and 2018, respectively.*

The change period over period in financing activities is partially due to higher borrowings of short-term debt, primarily under our commercial paper program of approximately $309 million to fund seasonal working capital and due to the timing of share repurchases in the quarter, partially offset by repurchases of common stock of approximately $100 million and higher dividend payments of approximately $31 million in the current period as a result of the dividend payment increase announced in December 2018.

*Cash provided (required) by financing activities of discontinued operations was $(37.2) million and zero for the three months ended March 31, 2019 and 2018, respectively.*

Cash required by financing activities of discontinued operations for the three months ended March 31, 2019 represents debt repayments as well as cash payments associated with the separation of FMC Lithium.

### Other potential liquidity needs

Our cash needs outside of the DuPont Crop Protection Business related integration expenses for 2019 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At March 31, 2019, our remaining borrowing capacity under our credit facility was $814.3 million (which includes borrowing capacity under our commercial paper program).

Projected 2019 capital expenditures as well as expenditures related to contract manufacturers are expected to be approximately $150 million, at the midpoint of the range, primarily driven by expenditures associated with capacity expansion. Additionally, we will continue to incur spending associated with the two-year implementation of a new SAP system.

As a result of the Act, we will continue to pay the remaining $161.3 million of transition tax over the next seven years.

Projected 2019 spending includes approximately $75 million to $80 million of net environmental remediation spending at both our continuing and discontinued sites. This projected spending for 2019 includes spending as a result of active negotiations for a settlement agreement primarily to address discontinued operations at our Middleport, New York site. This projected spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of "Costs of sales and services" in our condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we expect to make voluntary cash contributions of approximately $7 million during 2019. These projected contributions are in excess of the minimum requirements. We did not make any contributions in the first quarter of 2019. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the three months ended March 31, 2019 and 2018, we paid dividends of $53.2 million and $22.3 million, respectively. On April 18, 2019, we paid dividends totaling $52.8 million to our shareholders of record as of March 29, 2019. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of March 31, 2019.

During the three months ended March 31, 2019, 1.3 million shares were repurchased under the publicly announced repurchase program. At March 31, 2019, approximately $900 million remained unused under our Board-authorized repurchase program. We intend to purchase a total of up to $500 million of our common shares in 2019. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

### Commitments and Contingencies

See Note 19 to the condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2018 can be found in a table included within Part II, Item 7 of our 2018 Form 10-K. There have been no significant changes to our contractual commitments during the three months ended March 31, 2019.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2018 Form 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair Value Measurements

See Note 18 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At March 31, 2019, our financial instrument position was a net asset of $9.4 million compared to a net asset of $11.4 million at December 31, 2018. The change in the net financial instrument position was primarily due to changes in exchange and interest rates.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are diversified among electricity and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and electricity. To analyze the effect of changing energy prices, we perform a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at March 31, 2019 and December 31, 2018, with all other variables (including interest rates) held constant. Note, as of March 31, 2019 and December 31, 2018, we had no open commodity contracts. As a result, there was no sensitivity analysis performed over commodity price risk for the periods presented.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the Euro, the U.S. dollar versus the Chinese yuan, the U.S. dollar versus the Brazilian real and the U.S. dollar versus the Argentine peso. Foreign currency debt and foreign exchange forward contracts and options are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts and options are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at March 31, 2019 and December 31, 2018, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Condensed Consolidated Balance Sheets | 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset (liability) position at March 31, 2019** | $17.2 | $32.8 | $1.7 |
| **Net asset (liability) position at December 31, 2018** | $11.6 | $19.2 | $(16.7) |

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of March 31, 2019, we had outstanding interest rate swap contracts in place with an aggregate notional value of $500.0 million.

To analyze the effects of changing interest rates, we have performed a sensitivity analysis in which we assume an instantaneous one percent change in the interest rates from their levels at March 31, 2019 and December 31, 2018, with all other variables held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Condensed Consolidated Balance Sheets | 1% Increase | 1% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset (liability) position at March 31, 2019** | $(7.8) | $36.6 | $(45.3) |
| **Net asset (liability) position at December 31, 2018** | $(0.2) | $2.2 | $(2.7) |

Our debt portfolio, at March 31, 2019, is composed of 45 percent fixed-rate debt and 55 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2017 Term Loan Facility, Revolving Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at March 31, 2019, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $4.3 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $4.3 million for the three months ended March 31, 2019.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 4,232 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2019, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. On January 1, 2019, we adopted ASU No. 2016-02, *Leases (Topic 842)*. As part of our adoption activities, we assessed any potential impacts on our internal controls and processes related to both the implementation and ongoing compliance of the new guidance. As a result of this assessment, we have implemented updates and changes to our current processes related to leases and the control activities within them. These changes included updates to our lease accounting policies in order to be aligned with the new standard, implementing new lease identification and review controls specific to ASC 842, and the development of new processes for maintaining an accurate lease population and gathering data for the new disclosure requirements.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors

FMC Corporation:

#### Results of Review of Interim Financial Information

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries (the Company) as of March 31, 2019, the related condensed consolidated statements of income (loss), comprehensive income (loss), changes in equity and cash flows for the three-month periods ended March 31, 2019 and 2018, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2018, and the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2019, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2018, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

#### Basis for Review Results

This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

May 8, 2019

## Risk factors

As filed, 847 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A "Risk Factors" of our 2018 Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal year ended December 31, 2018 and the Company’s other filings with the SEC, which are available at www.sec.gov and on the Company’s website at www.fmc.com.

### Forward-Looking Information

We wish to caution readers not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date made. We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Filed May 8, 2019.
Source: SEC EDGAR, the filing index for accession 0000037785-19-000071. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
